Abstract:Introduction: Carbapenem resistant Acinetobacter baumannii (CRAB) has emerged worldwide, as an alarming pathogen causing healthcare associated infections. It mostly involves patients with impaired host defenses, and those with debilitating illnesses. CRAB is declared as the top priority pathogen by the World Health Organization for the development of new drugs. Aims & Objectives: i) To determine the frequency of isolation of Acinetobacter baumannii from clinical samples ii) To detect carbapenem resistance in clinical isolates of A. baumannii iii) To understand the risks factors associated with acquisition of CRAB. Methods: The clinical samples were subjected to culture i) by conventional methods as per standard bacteriological techniques, and ii) by an automated BACTEC System (BD). The isolates grown onto culture media were identied i) by conventional methods, and ii) by an automated VITEK 2 system (Biomerieux). Antibiotic susceptibility testing was performed i) by the Kirby Bauer disc diffusion method as per CLSI guidelines, and ii) by VITEK 2 system. All the meropenem resistant isolates of A. baumanni were subjected to i) Modied Hodge Test (MHT) for the production of carbapenemase, and ii) Combined Disk Test (CDT), using imipenem and EDTA, for the production of metallo-betalactamase. Results: The frequency of isolation of Acinetobacter species was found to be 5.7%, of which the predominant was A. baumanni (89.3%). Among the isolates of A. baumannii, the frequency of meropenem resistance was found to be 72.1%. Meropenem resistant isolates of A. baumannii were most commonly obtained from patients admitted in intensive care units (86.3%). CRAB isolates were most frequently recovered from endotracheal aspirate (34.2%), followed by pus (29.8%), blood (20.7%), sputum (8.2%) and urine (5.6%) The most common risk factor associated with CRAB was mechanical ventilation (35.5%), followed by previous antibiotic usage (28.5%), indwelling catheters (11.1%), prolonged hospitalization (9.7%), chronic obstructive pulmonary disease (8.1%) and diabetes (5.7%). Out of 922 CRAB isolates, 757 (82.1%) were carbapenemase producers. Among the CRAB isolates, 31.9% were found to be only MHT positive, 26.7% were only CDT positive, 23.5% were both MHT and CDT positive, and the remaining 17.9% were both MHT and CDT negative. Conclusion: Emergence of infections with CRAB emphasizes the need for continuous surveillance, judicious use of antibiotics, and implementation of aggressive infection control strategies.

Epidemiological investigation and control of carbapenem-resistant Acinetobacter baumannii infections in neurology department ICU

Investigation on epidemiology of carbapenem-resistant Acinetobacter baumannii and carbapenemases

Molecular Characterization of Carbapenem-Resistant Acinetobacter baumannii Isolates Among Intensive Care Unit Patients and Environment

Epidemiological Characteristics of Nosocomial Infections Caused by Carbapenem-Resistant Acinetobacter Baumannii

Prevalence and Mechanisms of Carbapenem Resistance among Klebsiella Aerogenes in a Tertiary Hospital in China

Current status of epidemiology of carbapenems-resistant Acinetobacter baumannii infections and effectiveness of infection control

Carbapenem-resistant Acinetobacter baumannii: A challenge in the intensive care unit

Epidemiological characteristics of carbapenem-resistant Acinetobacter baumannii hospital-associated infection in ICU patients of general hospitals

Epidemiological and genetic characteristics of clinical carbapenem-resistant Acinetobacter baumannii strains collected countrywide from hospital intensive care units (ICUs) in China

Clinical Distribution and Drug Resistance of Carbapenem-resistant Acinetobacter Baumannii

Molecular Epidemiological Investigation and Management of Outbreak Caused by Carbapenem-Resistant Acinetobacter baumannii in a Neonatal Intensive Care Unit

Molecular epidemiology and antimicrobial resistance patterns of carbapenem-resistant Acinetobacter baumannii isolates from patients admitted at ICUs of a teaching hospital in Zunyi, China

Monitoring and Control of Pan-Drug Resistant Acinetobacter Baumannii Colonization and Infection in a Medical Intensive Care Unit

Analysis of Risk Factors for Carbapenem-resistant Acinetobacter baumannii Infection in a Third Grade Class A Teaching Hospital

Comprehensive Surveillance and Sampling Reveal Carbapenem-Resistant Organism Spreading in Tertiary Hospitals in China

Resistant mechanisms and molecular epidemiological characteristics of carbapenem-resistant Acinetobacter baumannii

Intrahospital Dissemination of Carbapenem-Resistant Acinetobacter Baumannii and Analysis of the Infected Patients' Prognosis.

Risk Factors and Mortality of Patients with Nosocomial Carbapenem-Resistant Acinetobacter Baumannii Pneumonia.

Molecular Epidemiology of Multi-drug Resistant Acinetobacter Baumannii in ICU and Analysis of Carbapenem-resistant Genes

CARBAPENEM RESISTANT ACINETOBACTER BAUMANNII - A CHALLENGING THREAT IN HEALTHCARE

Whole genome sequencing and genomic characteristics analysis of carbapenem-resistant Acinetobacter baumannii clinical isolates in two hospitals in China